VAERS Explorer
Back to explore

Report #2884333

Received Feb 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Jan 29, 2026
Onset
Feb 1, 2026
Days to onset
3
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK—

Symptoms (6)

ArthralgiaImpaired work abilityInjection site erythemaInjection site swellingPainPyrexia

Symptom narrative

large red patch at injection site; swollen patch at the injection site; Low grade fever; Had to call out of work; sharp pains; Joint pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had shingles on ear and scalp in 2020). On 29-JAN-2026, the patient received the 1st dose of Shingles vaccine. In JAN-2026, less than a week after receiving Shingles vaccine, the patient experienced joint pain (Verbatim: Joint pain). On 01-FEB-2026, the patient experienced pain (Verbatim: sharp pains). On an unknown date, the patient experienced injection site erythema (Verbatim: large red patch at injection site), injection site swelling (Verbatim: swollen patch at the injection site), fever (Verbatim: Low grade fever) and impaired work ability (Verbatim: Had to call out of work). The outcome of the injection site erythema and injection site swelling were resolving and the outcome of the fever, impaired work ability and pain were not reported and the outcome of the joint pain was resolved (duration 36 hrs). It was unknown if the reporter considered the injection site erythema, injection site swelling, fever, impaired work ability, joint pain and pain to be related to Shingles vaccine. It was unknown if the company considered the injection site erythema, injection site swelling, fever, impaired work ability, joint pain and pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 01-FEB-2026 This case was reported by a patient via interactive digital media. The patient got the first shot on Thursday 29-JAN-2026. Patient had to call out of work, low grade fever and joint pain that lasted for about 36 hours or so. Patient still had quite a large red, swollen patch at the injection site. Feeling better overall. Patient had shingles on ear and scalp in 2020. Patient believed the stress of worrying about the Covid outbreak weakened immune system. Earlier today patient had sharp pains where shingles outbreak was on scalp and asked if any correlation. The batch number was not provided and unable to contact the reporter.

Medical history

Medical History/Concurrent Conditions: Shingles (had shingles on ear and scalp in 2020)